Personalized and Precision Medicine Journal

Abstract Background: Menopause comes along with a set of hormonal and physiological changes that can change cardiovascular responses during surgeries, along with altering pain perception. This research intends to analyze pain intensity during and after anesthesia and changes in hemodynamics in pre- and post-menopausal women during elective abdominal hysterectomy under general anesthesia.
Methods: Elective surgery patients, in this case, were 88 in number, with each division having 44 patients (before menopause and after). Women in each group were defined as premenopausal (n=44) and postmenopausal (n=44) in equal proportion. Other metrics looked at were Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP), also known as SpO₂. Patients’ heart rate and SpO₂ were checked during the surgery and after the surgery as well. Pain was assessed with the use of standardized scale methods, and participants were questioned on the pain felt during the post-operative period.
Results: While the premenopause cohort showed lower fluctuations in sensitivity to changes in SBP, DBP, and HR during and after anesthesia, the Postmenopause cohort exhibited the opposite (p<0.05). In each group, the SpO₂ levels were maintained within normal limits and showed no significant group differences. In the postoperative period, the pain score was significantly higher in the postmenopausal group with lower pain tolerance and a higher requirement for analgesic treatment. Spoken demographics such as age, body mass index (BMI), and other associated conditions showed a moderating influence on the hemodynamic response and pain outcomes.
Conclusion: Following menopause, diminished vascular adaptability, along with increased sympathetic tone and decreased central pain modulatory control due to lack of estrogen, might explain the instability of hemodynamics and increased postoperative pain. These observations could help in the formulation of appropriate anaesthetic techniques and postoperative pain relief policies in relation to the reproductive status of women.

Abstract Hysterectomy, the surgical excision of the uterus, has historically been fundamental in the management of gynecologic malignancies, encompassing endometrial, cervical, and ovarian cancers. Traditionally, hysterectomy has been executed via open abdominal surgery, a method that, although efficacious, frequently leads to extended recovery periods, heightened risk of complications, and greater psychological and physical strain for patients. In recent decades, substantial breakthroughs in surgical techniques and technology have fundamentally transformed the approach to these treatments, resulting in enhanced clinical outcomes, diminished complications, and expedited recovery periods. This study examines recent advancements in hysterectomy techniques, particularly highlighting the rise of minimally invasive approaches, including laparoscopic, robotic-assisted, and vaginal hysterectomy. These methods, characterized by smaller incisions and improved vision, are linked to many benefits, such as less blood loss, abbreviated hospital stays, and expedited resumption of normal activities. Furthermore, we examine the technical innovations that have significantly enhanced surgical precision, including 3D imaging, intraoperative molecular imaging, and real-time navigation systems.
These innovations have not only enhanced the effectiveness of treatment but have also contributed to a better overall quality of life for patients by reducing postoperative pain, minimizing scarring, and offering quicker recovery. Moreover, the psychological and emotional strains associated with cancer surgery, such as anxiety and body image concerns, are mitigated by less invasive techniques, resulting in enhanced patient satisfaction. Through this comprehensive analysis, the review highlights the transformative role of these technological and surgical advancements in gynecologic cancer treatment. These advancements enhance the precision and results of hysterectomy, reducing the long-term physical and psychological difficulties typically linked to cancer procedures, ultimately leading to improved treatment experiences and increased survival rates.